Monitoring Agency Report for the quarter ended March 31, 2026 - in relation to the Rights Issue of the Company.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Healthcare Global Enterprises Limited has submitted its first Monitoring Agency Report by CARE Ratings for the Rs. 424.68 crore Rights Issue that closed on March 25, 2026. The report shows nil utilization during Q4FY26, with all proceeds remaining in bank accounts (Axis Bank Monitoring Account: Rs. 424 crore and Collection Account: Rs. 0.68 crore). This is normal as the issue closed just days before quarter-end. The planned deployment includes: Rs. 170 crore for debt repayment, Rs. 154.04 crore for acquiring additional 34% stake in Vizag Hospital and Cancer Research Center Private Limited, Rs. 95.57 crore for general corporate purposes, and Rs. 5.07 crore for issue expenses. No deviations from stated objects were reported.
The nil utilization is procedural rather than concerning, given the issue closed March 25 and the quarter ended March 31. Shareholders should expect deployment to begin in Q1FY27. The significant allocation (Rs. 170 crore) for debt prepayment indicates management intends to reduce leverage, which could improve future profitability.